Back

Perrigo Company PLC

Ticker: PRGO ISIN: IE00BGH1M568
Add to portfolio Portfolio analysis in 2min
Stock Mid-cap Dividend payer
Market cap
$3.21B
Forward P/E
7.39
Profit margin
-3.63%
Revenue growth QoQ
-3.20%
Div. yield
4.70%
Beta
0.48
$14.48 2.84%
Price as of 2026-08-28 · NYSE

Performance by timeframe

Rolling returns
1 Month +43.34%
6 Months +22.87%
1 Year -33.26%
5 Years -14.64% p.a.-54.65%
10 Years -14.25% p.a.-78.48%
Since inception +1.20% p.a.+34.82%
Calendar year returns
YTD +11.37%
2025 -42.79%
2024 -16.92%
2023 -2.47%
2022 -9.78%
2021 -10.95%

Key stats

Market cap
3.21B
Dividend yield
4.70%
Beta
0.48
52-week range
23.14 - 32.66
50-day MA
26.62
200-day MA
27.63
Section 1

Business overview

Company profile data from fundamentals.

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Country Ireland
Exchange NYSE
Section 2

Financial quality

Profitability and balance-sheet quality indicators from reported fundamentals.

Profitability

ROE -3.16%
ROA 1.37%
Profit margin -3.63%
Operating margin 10.44%
PEG ratio 0.88
Revenue/share TTM 32.09
Revenue TTM 4.39B
EBITDA 571.90M
Gross profit TTM 1.58B
Beta 0.48

Valuation

Trailing P/E 0.00
Forward P/E 7.39
P/B 0.70
P/S 0.73
EV/EBITDA 20.70
EV/Revenue 1.48

ESG Scores

Total ESG 39.8
Environment 2.6
Social 20.2
Governance 11.5
Section 3

Earnings

Earnings metrics from company highlights and earnings datasets.

EPS estimate (current year) 2.57
Quarterly earnings growth -63.60%
Revenue TTM 4.39B
Reported quarters 117
Section 4

Dividends & corporate actions

Dividend and split fields from fundamentals.

Dividend yield 4.70%
Forward annual div. yield 4.70%
Dividend per share 1.1010
Payout ratio 44.34%
Ex-dividend date 2024-11-29
Split factor 2:1
Last split date 1993-08-26
Section 5

Ownership / analyst view

Institutional ownership and analyst estimate fields when available.

Analyst

Analyst target price $34.20
Analyst rating 4

Ownership & short interest

Shares outstanding 136.43M
Shares float 135.61M
Institutional ownership 100.06%
Insider ownership 31.00%
Short ratio 3.59
Short % of float 3.71%

Details

Instrument metadata and source update timestamps.

Symbol PRGO
Name Perrigo Company PLC
Asset type STOCK
Exchange NYSE
Currency USD
ISIN IE00BGH1M568
Country USA
Code + exchange PRGO.NYSE
Last price date 2025-01-15
Fundamentals updated 2025-01-16

The information provided on this platform is for informational purposes only and should not be considered as financial or investment advice. Insightfolio does not provide investment advice, personalized recommendations, or guidance regarding the purchase, holding, or sale of financial assets. The tools and content are intended for educational purposes only and are not tailored to individual circumstances, financial needs, or objectives.

Insightfolio assumes no liability for the accuracy, completeness, or reliability of the information presented. Users are solely responsible for verifying the information and making independent decisions based on their own research and careful consideration. Use of the platform should not replace consultation with qualified financial professionals.

Investments involve risks. Users should be aware that the value of investments may fluctuate and that past performance is not an indicator of future results. Investment decisions should be based on personal financial goals, risk tolerance, and independent evaluation of relevant information.

Insightfolio does not endorse or guarantee the suitability of any particular financial product, security, or strategy. Any projections, forecasts, or hypothetical scenarios presented on the platform are for illustrative purposes only and are not guarantees of future outcomes.

By accessing the services, information, or content offered by Insightfolio, users acknowledge and agree to these terms of the disclaimer. If you do not agree to these terms, please do not use our platform.

Instrument logos provided by Elbstream.